How important are quality-of-life measures in RA and how effective are IL-6 inhibitors in this regard compared to TNFIs according to the latest clinical studies?

How important are quality-of-life measures in RA and how effective are IL-6 inhibitors in this regard compared to TNFIs according to the latest clinical studies?

How important are quality-of-life measures in RA and how effective are IL-6 inhibitors in this regard compared to TNFIs according to the latest clinical studies?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

William Shergy, MD

William Shergy, MD

Associate Clinical Professor of Medicine
University of Alabama at Birmingham
School of Medicine
Huntsville, Alabama
Assistant Consulting Professor of Medicine
Duke University Medical Center
Durham, North Carolina